- Home
- LUCY vs CVKD Comparison
LUCY vs CVKD Comparison
Compare LUCY & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LUCY | CVKD |
|---|---|---|
| Founded | 2017 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 20.7M |
| IPO Year | 2022 | 2023 |
Fundamental Metrics
Financial Performance| Metric | LUCY | CVKD |
|---|---|---|
| Price | $1.11 | $6.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | ★ 257.0K | 81.7K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,392,547.00 | N/A |
| Revenue This Year | $80.76 | N/A |
| Revenue Next Year | $210.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 53.22 | N/A |
| 52 Week Low | $1.21 | $6.75 |
| 52 Week High | $7.08 | $22.90 |
Technical Indicators
Market Signals| Indicator | LUCY | CVKD |
|---|---|---|
| Relative Strength Index (RSI) | 28.61 | 34.12 |
| Support Level | $1.36 | $6.75 |
| Resistance Level | $1.43 | $7.62 |
| Average True Range (ATR) | 0.11 | 0.96 |
| MACD | -0.02 | -0.18 |
| Stochastic Oscillator | 1.09 | 2.58 |
Price Performance
Historical ComparisonAbout LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.